Survivors of a pediatric malignancy are at risk for serious long-term morbidity and premature mortality related to their treatment. Women who were treated with chest radiation for their childhood cancer have an increased risk of developing breast cancer at a young age. We use the term chest radiation to refer to radiation that includes the following fields: mantle, mediastinal, lung, total body irradiation, or spinal. Models for predicting the absolute risk of breast cancer, such as the well-known Gail model, have been used extensively to advise patients on their individual risk of developing breast cancer and to design prevention trials. The majority of these risk calculators are not immediately applicable to survivors of a previous malignancy who have a risk that is modified by previous treatments. Moreover, there is conflicting evidence as to whether various non-treatment related factors, including the traditional breast cancer risk factors, are associated with the risk of breast cancer in these women. The traditional risk factors include age, age at menarche, age at birth of first live child, number of first-degree relatives with breast cancer, number of previous breast biopsies, and history of atypical hyperplasia. We propose to utilize the unique resources of the North American Childhood Cancer Survivor Study (CCSS) and the Dutch LATe Effect Registry (LATER) cohorts.
Our first aim i s to develop a risk prediction model that integrates chest radiation dose and volume, treatment-related exposures, the traditional risk factors, and other possible risk factors such as age at menopause, body mass index, the number of years with intact ovarian function after radiotherapy, and use of hormone replacement or oral contraceptive therapy, in order to estimate the individualized absolute risk of breast cancer for women who were treated with chest radiation for a childhood cancer. The model will be developed using the original CCSS cohort in which there are 1,677 female participants who were treated with chest radiation and would be included in this analysis. Of these 1,677 women, 187 women had developed breast cancer by the time of this application.
Our second aim i s to validate the prediction model on independent data. The validation cohort will consist of about 1225 female participants in the expanded CCSS cohort and 1087 female participants in the Dutch LATER cohort. We estimate that approximately 100 of these women will have breast cancer.
The third aim i s to create and disseminate a risk calculator that provides computer-assisted risk prediction. Our objective is to present a tool in an easily accessible format and disseminate it for clinical use by physicians and patients. The long-term goals of this project are to provide a means for facilitating conversations between physicians and their patients about appropriate screening and preventive strategies and to help refine screening recommendations for this population.

Public Health Relevance

Women who were treated with chest radiation for a childhood cancer are at risk of developing breast cancer at a young age.
We aim to quantify a woman's individualized risk of breast cancer as a function of the dose of radiation to the chest, other treatment-related factors, the traditional breast cancer risk factors such as family and reproductive histories, and other non-treatment related risk factors. This risk prediction model has the potential to facilitate conversations between physicians and patients and to help refine current screening recommendations for female survivors of a pediatric cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA136783-03
Application #
8210899
Study Section
Special Emphasis Panel (ZRG1-PSE-B (02))
Program Officer
Shelburne, Nonniekaye F
Project Start
2010-04-01
Project End
2014-01-31
Budget Start
2012-02-01
Budget End
2013-01-31
Support Year
3
Fiscal Year
2012
Total Cost
$385,034
Indirect Cost
$131,047
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Heller, Glenn; Seshan, Venkatraman E; Moskowitz, Chaya S et al. (2017) Inference for the difference in the area under the ROC curve derived from nested binary regression models. Biostatistics 18:260-274
Moskowitz, Chaya S; Chou, Joanne F; Sklar, Charles A et al. (2017) Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study. Br J Cancer 117:290-299
Henderson, Tara O; Moskowitz, Chaya S; Chou, Joanne F et al. (2016) Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 34:910-8
Moskowitz, Chaya S; Malhotra, Jyoti; Chou, Joanne F et al. (2015) Breast cancer following spinal irradiation for a childhood cancer: A report from the Childhood Cancer Survivor Study. Radiother Oncol 117:213-6
Rosenberg, Shoshana M; Moskowitz, Chaya S; Ford, Jennifer S et al. (2015) Health care utilization, lifestyle, and emotional factors and mammography practices in the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 24:1699-706
Moskowitz, Chaya S; Chou, Joanne F; Wolden, Suzanne L et al. (2014) Breast cancer after chest radiation therapy for childhood cancer. J Clin Oncol 32:2217-23
Moskowitz, Chaya S; Oeffinger, Kevin C (2014) Predicting Adverse Health Outcomes in Long-Term Survivors of a Childhood Cancer. Children (Basel) 1:63-73
Oeffinger, Kevin C; Baxi, Shrujal S; Novetsky Friedman, Danielle et al. (2013) Solid tumor second primary neoplasms: who is at risk, what can we do? Semin Oncol 40:676-89
Seshan, Venkatraman E; Gonen, Mithat; Begg, Colin B (2013) Comparing ROC curves derived from regression models. Stat Med 32:1483-93
Begg, Colin B; Gonen, Mithat; Seshan, Venkatraman E (2013) Testing the incremental predictive accuracy of new markers. Clin Trials 10:690-2

Showing the most recent 10 out of 11 publications